Search
Now showing items 1-10 of 12
Rapid, complex adaption of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression.
(Wolters Kluwer Health., 2013)
Objective(s): There is limited information on full-length genome sequences and the
early evolution of transmitted HIV-1 subtype C viruses, which constitute the majority of
viruses spread in Africa. The purpose of this ...
Brief report: selection of HIV-1 variants with higher transmission potential by 1% tenofovir gel microbicide.
(Wolters Kluwer Health., 2017)
Abstract available in pdf.
Characterization of nucleoside reverse transcriptase inhibitor-associated mutations in the RNAse H region of HIV-1 subtype c infected individuals.
(Viruses., 2017)
Abstract available in pdf.
Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.
(Wolters Kluwer Health., 2016)
Abstract available in PDF file.
Association of polymorphisms in the regulatory region of the cyclophilin A gene (PPIA) with gene expression and HIV/AIDS disease progression.
(Wolters Kluwer Health., 2016)
Abstract available in PDF file.
Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
(Elsevier Ltd., 2015)
Abstract available in pdf.
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
(American Association for the Advancement of Science., 2017)
Abstract available in pdf.
The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.
(Journal of Clinical Virology, 2017-09)
Abstract available in pdf.
HIV prevention trial design in an era of effective pre-exposure prophylaxis.
(American Association for the Advancement of Science., 2017)
Abstract available in pdf.
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
(Elsevier, 2008)
Identifying the earliest neutralizing antibody specificities that are elicited following infection or vaccination
by HIV-1 is an important objective of current HIV/AIDS vaccine research. We have shown previously ...